STRO vs MTVA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
STRO Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sutro Biopharma, Inc. (STRO) driven by superior Valuation, Momentum & Technical, Options & Structure while MTVA counters with relative strength in Growth & Margin. Fundamentally, STRO trades at 10.0x Forward P/E with -254.7% operating margin (-6.1% YoY revenue) versus MTVA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, STRO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | STRO | MTVA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $144.8M | $7.2M | Larger Scale | STRO |
| Trailing P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | STRO |
| Forward P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | STRO |
| Revenue Growth (YoY) Growth | -6.1% | +0.0% | Higher Growth | MTVA |
| Operating Margin (TTM) Profitability | -254.7% | 0.0% | Higher Margin | MTVA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1810.0% | -175.7% | Higher ROE | MTVA |
| 52-Week Range Position Momentum | 18% ($1โ$44) | 4% ($1โ$13) | Stronger Trend | STRO |
| Beta / 30D Volatility Risk Regime | 1.46ฮฒ ยท 76% Vol | 1.30ฮฒ ยท 166% Vol | Lower Realized Risk | STRO |
| Unified Institutional Score Composite Signal | 44.1 / 100 (HOLD) | 48.0 / 100 (HOLD) | Higher Composite | MTVA |